DECOR-informatie voor project: Ketenzorg (kz-) |
VZVZ Verwijzing Huisarts Zorggroep 2.16.840.1.113883.2.4.3.11.60.66.10.1 - 2014‑01‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | ZTKZ_IN000001NL | verwijzingHuisartsZorggroep | kz-verwijzingHuisartsZorggroep.sch |
VZVZ Ontvangstbevestiging 2.16.840.1.113883.2.4.3.11.60.66.10.90 - 2014‑01‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | MCCI_IN000002 | verwijzingHuisartsZorggroep-ack | kz-verwijzingHuisartsZorggroep-ack.sch |
VZVZ Overdracht Zorggroep Huisarts 2.16.840.1.113883.2.4.3.11.60.66.10.2 - 2014‑01‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | ZTKZ_IN000004NL | overdrachtZorggroepHuisarts | kz-overdrachtZorggroepHuisarts.sch |
VZVZ Ontvangstbevestiging 2.16.840.1.113883.2.4.3.11.60.66.10.90 - 2014‑01‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | MCCI_IN000002 | overdrachtZorggroepHuisarts-ack | kz-overdrachtZorggroepHuisarts-ack.sch |
VZVZ Verwijzing Afbreken Huisarts Zorggroep 2.16.840.1.113883.2.4.3.11.60.66.10.21 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | ZTKZ_IN000005NL | verwijzingAfbrekenHuisartsZorggroep | kz-verwijzingAfbrekenHuisartsZorggroep.sch |
VZVZ Ontvangstbevestiging 2.16.840.1.113883.2.4.3.11.60.66.10.90 - 2014‑01‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | MCCI_IN000002 | verwijzingAfbrekenHuisartsZorggroep-ack | kz-verwijzingAfbrekenHuisartsZorggroep-ack.sch |
VZVZ Generieke Query Zorggegevens 2.16.840.1.113883.2.4.3.11.60.66.10.3 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | GQZG_IN000001NL | generiekeQueryZorggegevens | kz-generiekeQueryZorggegevens.sch |
VZVZ Batch antwoord 2.16.840.1.113883.2.4.3.11.60.66.10.4 - 2015‑07‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | MCCI_IN200101 | batchAntwoord | kz-batchAntwoord.sch |
VZVZ Opvragen Labuitslagen 2.16.840.1.113883.2.4.3.11.60.66.10.5 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | POLB_IN354001NL02 | opvragenLabUitslagen | kz-opvragenLabUitslagen.sch |
VZVZ Opleveren Labuitslagen 2.16.840.1.113883.2.4.3.11.60.66.10.6 - 2014‑08‑18
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | POLB_IN364001NL02 | opleverenLabUitslagen | kz-opleverenLabUitslagen.sch |
VZVZ Opvragen Algemene Uitslagen 2.16.840.1.113883.2.4.3.11.60.66.10.7 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | POOB_IN990001NL | opvragenAlgemeneUitslagen | kz-opvragenAlgemeneUitslagen.sch |
VZVZ Opleveren Algemene Uitslagen 2.16.840.1.113883.2.4.3.11.60.66.10.8 - 2014‑08‑18
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | POOB_IN990003NL | opleverenAlgemeneUitslagen | kz-opleverenAlgemeneUitslagen.sch |
VZVZ Opvragen Contactmomenten 2.16.840.1.113883.2.4.3.11.60.66.10.9 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | PRPA_IN900300NL | opvragenContactmomenten | kz-opvragenContactmomenten.sch |
VZVZ Opleveren Contactmomenten 2.16.840.1.113883.2.4.3.11.60.66.10.10 - 2014‑08‑18
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | PRPA_IN900350NL | opleverenContactmomenten | kz-opleverenContactmomenten.sch |
VZVZ Opvragen Medicatievoorschriften 2.16.840.1.113883.2.4.3.11.60.66.10.11 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | QURX_IN990201NL01 | opvragenVoorschriften | kz-opvragenVoorschriften.sch |
VZVZ Opleveren Medicatievoorschriften 2.16.840.1.113883.2.4.3.11.60.66.10.12 - 2014‑08‑18
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | QURX_IN990203NL01 | opleverenVoorschriften | kz-opleverenVoorschriften.sch |
VZVZ Opvragen Contactverslagen 2.16.840.1.113883.2.4.3.11.60.66.10.13 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | REPC_IN990100NL | opvragenContactverslagen | kz-opvragenContactverslagen.sch |
VZVZ Opleveren Contactverslagen 2.16.840.1.113883.2.4.3.11.60.66.10.14 - 2015‑06‑01
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | REPC_IN990101NL | opleverenContactverslagen | kz-opleverenContactverslagen.sch |
VZVZ Opvragen Overdrachtconcerns 2.16.840.1.113883.2.4.3.11.60.66.10.15 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | REPC_IN990110NL | opvragenOverdrachtconcerns | kz-opvragenOverdrachtconcerns.sch |
VZVZ Opleveren Overdrachtconcerns 2.16.840.1.113883.2.4.3.11.60.66.10.16 - 2015‑06‑01
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | REPC_IN990111NL | opleverenOverdrachtconcerns | kz-opleverenOverdrachtconcerns.sch |
VZVZ Opvragen Alerts 2.16.840.1.113883.2.4.3.11.60.66.10.17 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | REPC_IN990120NL | opvragenAlerts | kz-opvragenAlerts.sch |
VZVZ Opleveren Alerts 2.16.840.1.113883.2.4.3.11.60.66.10.18 - 2015‑06‑01
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | REPC_IN990121NL | opleverenAlerts | kz-opleverenAlerts.sch |
VZVZ Opvragen Allergie intoleranties 2.16.840.1.113883.2.4.3.11.60.66.10.19 - 2015‑11‑13
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
initiërend | REPC_IN990130NL | opvragenAllergieintoleranties | kz-opvragenAllergieintoleranties.sch |
VZVZ Opleveren Allergie intoleranties 2.16.840.1.113883.2.4.3.11.60.66.10.20 - 2015‑06‑01
| Richting | Onderliggend model | Templatenaam | Schematron | |
|---|---|---|---|---|
![]() |
reagerend | REPC_IN990131NL | opleverenAllergieintoleranties | kz-opleverenAllergieintoleranties.sch |
Active Ingredient CDA 2.16.840.1.113883.2.4.3.11.60.20.77.10.117 - 2013‑12‑21 ref (van repository: mp-)
Adres 2.16.840.1.113883.2.4.3.11.60.101.10.2 - 2014‑11‑06 ref (van repository: naw-)
Age Observation 2.16.840.1.113883.10.20.22.4.31 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
Age Observation 2.16.840.1.113883.10.20.22.4.31 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Annotation Comment 1.3.6.1.4.1.19376.1.5.3.1.4.2 - 2009‑12‑04 ref (van repository: iheptv-)
VZVZ AttentionLine ContextCode 2.16.840.1.113883.2.4.3.11.60.66.10.9022 - 2014‑09‑10
Author Participation 2.16.840.1.113883.10.20.22.4.119 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
CDA AssignedEntity 2.16.840.1.113883.2.4.3.11.60.20.77.10.9013 - 2015‑11‑27 ref (van repository: mp-)
PART CDA Assigned Entity 2.16.840.1.113883.2.4.3.11.60.66.10.9003 - 2013‑12‑22
CDA Author (Body) 2.16.840.1.113883.2.4.3.11.60.20.77.10.9007 - 2015‑11‑25 ref (van repository: mp-)
CDA Author (Body) 2.16.840.1.113883.2.4.3.11.60.20.77.10.9007 - 2013‑12‑21 ref (van repository: mp-)
PART CDA Author (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9011 - 2014‑04‑03 16:28:02
CDA Device 2.16.840.1.113883.2.4.3.11.60.20.77.10.9012 - 2013‑12‑21 ref (van repository: mp-)
PART CDA Device 2.16.840.1.113883.2.4.3.11.60.66.10.9008 - 2014‑04‑03 15:47:26
PART CDA Observation Reference Range 2.16.840.1.113883.2.4.3.11.60.66.10.9005 - 2013‑12‑27
CDA Organization 2.16.840.1.113883.2.4.3.11.60.20.77.10.9011 - 2013‑12‑21 ref (van repository: mp-)
PART CDA Organization 2.16.840.1.113883.2.4.3.11.60.66.10.9002 - 2011‑12‑19
PART CDA Participant (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9007 - 2014‑04‑03
15:25:16
CDA Participant Contact Person 2.16.840.1.113883.2.4.3.11.60.66.10.106 - 2014‑11‑13
CDA Participant Primary Care Physician 2.16.840.1.113883.2.4.3.11.60.66.10.107 - 2014‑11‑13
PART CDA Performer (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9012 - 2014‑04‑03
16:28:20
PART CDA Performer Supplier (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9036 - 2015‑07‑13
CDA Person 2.16.840.1.113883.2.4.3.11.60.20.77.10.9010 - 2013‑12‑21 ref (van repository: mp-)
PART CDA Person 2.16.840.1.113883.2.4.3.11.60.66.10.9001 - 2013‑12‑22
PART CDA PlayingEntity 2.16.840.1.113883.2.4.3.11.60.66.10.9009 - 2014‑04‑03 15:47:46
CDA RelatedEntity 2.16.840.1.113883.2.4.3.11.60.20.77.10.9014 - 2013‑12‑21 ref (van repository: mp-)
PART CDA RelatedEntity 2.16.840.1.113883.2.4.3.11.60.66.10.9021 - 2014‑08‑18 13:56:46
PART CDA Responsible Party (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9015 - 2014‑04‑30
10:28:20
PART CDA Specimen 2.16.840.1.113883.2.4.3.11.60.66.10.9006 - 2014‑04‑03 15:10:18
PART CDA Subject (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9010 - 2014‑04‑03 15:50:23
KEZO CDA author 2.16.840.1.113883.2.4.3.11.60.66.10.102 - 2014‑06‑27
PART CDA confidentialityCode 2.16.840.1.113883.2.4.3.11.60.66.10.9020 - 2014‑06‑27
KEZO CDA custodian 2.16.840.1.113883.2.4.3.11.60.66.10.103 - 2014‑06‑27
PART CDA effectiveTime 2.16.840.1.113883.2.4.3.11.60.66.10.9019 - 2014‑06‑27
PART CDA id 2.16.840.1.113883.2.4.3.11.60.66.10.9017 - 2014‑06‑27
KEZO CDA Informant 2.16.840.1.113883.2.4.3.11.60.66.10.104 - 2014‑08‑18 13:50:32
CDA Informant (Body) 2.16.840.1.113883.2.4.3.11.60.20.77.10.9008 - 2013‑12‑21 ref (van repository: mp-)
PART CDA languageCode 2.16.840.1.113883.2.4.3.11.60.66.10.9027 - 2014‑10‑06
PART CDA realmCode 2.16.840.1.113883.2.4.3.11.60.66.10.9026 - 2014‑10‑06
KEZO CDA recordTarget 2.16.840.1.113883.2.4.3.11.60.66.10.101 - 2014‑06‑27
KEZO CDA recordTarget BSN only 2.16.840.1.113883.2.4.3.11.60.66.10.108 - 2014‑11‑18
KEZO CDA recordTarget Minimal 2.16.840.1.113883.2.4.3.11.60.66.10.105 - 2014‑08‑18
PART CDA title 2.16.840.1.113883.2.4.3.11.60.66.10.9018 - 2014‑06‑27
PART CDA typeId 2.16.840.1.113883.2.4.3.11.60.66.10.9016 - 2014‑06‑27
Person [contact] 2.16.840.1.113883.2.4.3.11.60.102.10.518 - 2012‑09‑01 ref (van repository: hl7m-)
Notification Party [contact] 2.16.840.1.113883.2.4.3.11.60.102.10.516 - 2012‑09‑01
ref (van repository: hl7m-)
Organization [contact] 2.16.840.1.113883.2.4.3.11.60.102.10.517 - 2012‑09‑01 ref (van repository: hl7m-)
Comment Activity 2.16.840.1.113883.10.20.22.4.64 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
Comment Activity 2.16.840.1.113883.10.20.22.4.64 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
PART Concern reference 2.16.840.1.113883.2.4.3.11.60.66.10.9014 - 2014‑04‑10
PART Contact reference 2.16.840.1.113883.2.4.3.11.60.66.10.9013 - 2014‑04‑10
VZVZ ControlAct Overseer Person 2.16.840.1.113883.2.4.3.11.60.66.10.9023 - 2014‑09‑22
VZVZ ControlAct Overseer Person MCAI 2.16.840.1.113883.2.4.3.11.60.66.10.9024 - 2014‑09‑22
Encounter Activities 2.16.840.1.113883.10.20.22.4.49 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Encounter Activity (V3) 2.16.840.1.113883.10.20.22.4.49 - 2015‑08‑01 (2.1) ref (van repository: ccda-)
Encounter Diagnosis 2.16.840.1.113883.10.20.22.4.80 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Encounter Diagnosis (V3) 2.16.840.1.113883.10.20.22.4.80 - 2015‑08‑01 (2.1) ref (van repository: ccda-)
Entry Reference 2.16.840.1.113883.10.20.22.4.122 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
Frequency 2.16.840.1.113883.2.4.3.11.60.20.77.10.9020 - 2015‑03‑05 13:41:39 ref (van repository: mp-)
Health Status Observation 2.16.840.1.113883.10.20.22.4.5 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Indication 2.16.840.1.113883.10.20.22.4.19 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Indication (V2) 2.16.840.1.113883.10.20.22.4.19 - 2014‑06‑09 (2.1) ref (van repository: ccda-)
Ingredient Material Kind CDA 2.16.840.1.113883.2.4.3.11.60.20.77.10.118 - 2013‑05‑21
ref (van repository: mp-)
Laboratory Observation 1.3.6.1.4.1.19376.1.3.1.6 - 2008‑08‑08 ref (van repository: iheptv-)
Medication Administration Instruction CDA 2.16.840.1.113883.2.4.3.11.60.20.77.10.113 - 2013‑12‑21
ref (van repository: mp-)
Medication Code 2.16.840.1.113883.2.4.3.11.60.20.77.10.9005 - 2013‑05‑21 ref (van repository: mp-)
Medication Information 2.16.840.1.113883.2.4.3.11.60.20.77.10.116 - 2013‑12‑21
ref (van repository: mp-)
Medication or Material Code Ext 2.16.840.1.113883.2.4.3.11.60.20.77.10.9016 - 2013‑05‑21
ref (van repository: mp-)
MP Medication Supply Order 2.16.840.1.113883.2.4.3.11.60.20.77.10.123 - 2014‑04‑30
NHG Tabel 25 B-codes 2.16.840.1.113883.2.4.3.11.60.20.77.10.9000 - 2013‑05‑21 ref (van repository: mp-)
Naam persoon 2.16.840.1.113883.2.4.3.11.60.101.10.1 - 2014‑11‑06 ref (van repository: naw-)
Other Ingredient CDA 2.16.840.1.113883.2.4.3.11.60.20.77.10.119 - 2013‑05‑21 ref (van repository: mp-)
Patient Referral Act 2.16.840.1.113883.10.20.22.4.140 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
Priority Preference 2.16.840.1.113883.10.20.22.4.143 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
Problem Observation 2.16.840.1.113883.10.20.22.4.4 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Problem Observation (V3) 2.16.840.1.113883.10.20.22.4.4 - 2015‑08‑01 (2.1) ref (van repository: ccda-)
Problem Status 2.16.840.1.113883.10.20.22.4.6 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Problem Status (DEPRECATED) 2.16.840.1.113883.10.20.22.4.6 - 2014‑06‑09 (2.1) ref (van repository: ccda-)
Prognosis Observation 2.16.840.1.113883.10.20.22.4.113 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
Reason for Referral Section 1.3.6.1.4.1.19376.1.5.3.1.3.1 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Reason for Referral Section (V2) 1.3.6.1.4.1.19376.1.5.3.1.3.1 - 2014‑06‑09 (2.1)
ref (van repository: ccda-)
Related Prescription 2.16.840.1.113883.2.4.3.11.60.20.77.10.115 - 2013‑12‑21 ref (van repository: mp-)
Result Observation 2.16.840.1.113883.10.20.22.4.2 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
Result Observation (V3) 2.16.840.1.113883.10.20.22.4.2 - 2015‑08‑01 (2.1) ref (van repository: ccda-)
Service Delivery Location 2.16.840.1.113883.10.20.22.4.32 - 2015‑08‑13 (2.1) ref (van repository: ccda-)
Service Delivery Location 2.16.840.1.113883.10.20.22.4.32 - 2013‑01‑31 (1.1) ref (van repository: ccda-)
TransmissionWrapper Device 2.16.840.1.113883.2.4.3.11.60.102.10.110 - 2014‑07‑15
ref (van repository: hl7m-)
VZVZ TransmissionWrapper Accept Ack 2.16.840.1.113883.2.4.3.11.60.66.10.91 - 2014‑01‑13
Usable Period 2.16.840.1.113883.2.4.3.11.60.20.77.10.9019 - 2013‑05‑21 ref (van repository: mp-)
Usable Period and Frequency 2.16.840.1.113883.2.4.3.11.60.20.77.10.9006 - 2013‑05‑21
ref (van repository: mp-)
GEBB Comment Activity 2.16.840.1.113883.2.4.3.11.60.2.10.6 - 2014‑03‑31
GEBB Encounter Activity 2.16.840.1.113883.2.4.3.11.60.2.10.1 - 2013‑12‑31
GEBB Encounter Diagnosis 2.16.840.1.113883.2.4.3.11.60.2.10.4 - 2013‑01‑31
GEBB Indication 2.16.840.1.113883.2.4.3.11.60.2.10.3 - 2013‑01‑31
GEBB Laboratory Observation 2.16.840.1.113883.2.4.3.11.60.2.10.5 - 2014‑03‑31
GEBB Result Observation 2.16.840.1.113883.2.4.3.11.60.2.10.7 - 2013‑01‑31
GEBB Service Delivery Location 2.16.840.1.113883.2.4.3.11.60.2.10.2 - 2013‑12‑31
KEZO Alert 2.16.840.1.113883.2.4.3.11.60.66.10.214 - 2015‑11‑25
KEZO Alert 2.16.840.1.113883.2.4.3.11.60.66.10.214 - 2015‑07‑11
KEZO Algemene bepaling 2.16.840.1.113883.2.4.3.11.60.66.10.202 - 2013‑12‑31
KEZO Allergie Intolerantie Observatie 2.16.840.1.113883.2.4.3.11.60.66.10.216 - 2015‑07‑15
KEZO Allergy Concern 2.16.840.1.113883.2.4.3.11.60.66.10.215 - 2015‑07‑15
KEZO Assessment 2.16.840.1.113883.2.4.3.11.60.66.10.210 - 2015‑06‑01
KEZO PART CDA Assigned Entity 2.16.840.1.113883.2.4.3.11.60.66.10.9028 - 2014‑11‑10
KEZO PART CDA Author (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9025 - 2014‑04‑03
16:28:02
KEZO PART CDA Dossierhouder 2.16.840.1.113883.2.4.3.11.60.66.10.9032 - 2014‑11‑13
KEZO PART CDA Inhoudsverantwoordelijke 2.16.840.1.113883.2.4.3.11.60.66.10.9031 - 2014‑11‑13
KEZO PART CDA Participant (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9029 - 2014‑11‑13
KEZO PART CDA Responsible Party (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9030 - 2014‑11‑13
KEZO PART CDA componentOf minimal 2.16.840.1.113883.2.4.3.11.60.66.10.9033 - 2014‑11‑13
KEZO Clinical Information Section 2.16.840.1.113883.2.4.3.11.60.66.10.301 - 2014‑06‑27
KEZO Contactmoment 2.16.840.1.113883.2.4.3.11.60.66.10.201 - 2015‑07‑08
KEZO Contactmoment 2.16.840.1.113883.2.4.3.11.60.66.10.201 - 2013‑12‑31
KEZO Contactverslag 2.16.840.1.113883.2.4.3.11.60.66.10.207 - 2015‑06‑01
KEZO Criticality Observatie 2.16.840.1.113883.2.4.3.11.60.66.10.218 - 2015‑08‑21
KEZO Criticality Observatie 2.16.840.1.113883.2.4.3.11.60.66.10.218 - 2015‑07‑15
KEZO Exposure Route 2.16.840.1.113883.2.4.3.11.60.66.10.220 - 2015‑07‑15
KEZO Indicatie Diagnose 2.16.840.1.113883.2.4.3.11.60.66.10.205 - 2014‑04‑30
KEZO Labbepaling 2.16.840.1.113883.2.4.3.11.60.66.10.203 - 2014‑04‑03
KEZO Objective 2.16.840.1.113883.2.4.3.11.60.66.10.209 - 2015‑06‑01
KEZO PART CDA Allergen 2.16.840.1.113883.2.4.3.11.60.66.10.9037 - 2015‑07‑15
KEZO Verwijzing 2.16.840.1.113883.2.4.3.11.60.66.10.206 - 2014‑06‑27
KEZO Plan 2.16.840.1.113883.2.4.3.11.60.66.10.211 - 2015‑06‑01
KEZO Plan of Care Section 2.16.840.1.113883.2.4.3.11.60.66.10.304 - 2014‑09‑10
KEZO Overdracht Concern 2.16.840.1.113883.2.4.3.11.60.66.10.212 - 2015‑07‑03
KEZO Probleem 2.16.840.1.113883.2.4.3.11.60.66.10.213 - 2015‑07‑03
KEZO PART QRY contextCode 2.16.840.1.113883.2.4.3.11.60.66.10.9038 - 2015‑07‑11
KEZO PART QRY effectiveTimeInterval 2.16.840.1.113883.2.4.3.11.60.66.10.9034 - 2015‑06‑01
KEZO PART QRY patientId 2.16.840.1.113883.2.4.3.11.60.66.10.9035 - 2015‑06‑01
KEZO PART QRY problemCode 2.16.840.1.113883.2.4.3.11.60.66.10.9040 - 2015‑11‑13
KEZO Reactie Observatie 2.16.840.1.113883.2.4.3.11.60.66.10.217 - 2015‑07‑15
KEZO Reason for Referral Section 2.16.840.1.113883.2.4.3.11.60.66.10.303 - 2015‑11‑15
KEZO Reason for Referral Section 2.16.840.1.113883.2.4.3.11.60.66.10.303 - 2014‑09‑10
KEZO Severity Observatie 2.16.840.1.113883.2.4.3.11.60.66.10.219 - 2015‑07‑15
KEZO Subjective 2.16.840.1.113883.2.4.3.11.60.66.10.208 - 2015‑06‑01
KEZO Summary Section 2.16.840.1.113883.2.4.3.11.60.66.10.302 - 2015‑07‑13
KEZO Summary Section 2.16.840.1.113883.2.4.3.11.60.66.10.302 - 2014‑06‑27
KEZO PART CDA Verfifier (Body) 2.16.840.1.113883.2.4.3.11.60.66.10.9039 - 2015‑08‑30
KEZO Voorschrift 2.16.840.1.113883.2.4.3.11.60.66.10.204 - 2015‑09‑09
KEZO Voorschrift 2.16.840.1.113883.2.4.3.11.60.66.10.204 - 2015‑07‑08
KEZO Voorschrift 2.16.840.1.113883.2.4.3.11.60.66.10.204 - 2014‑04‑30
KEZO Clinical Document Afbreken Verwijzing 2.16.840.1.113883.2.4.3.11.60.66.10.52 - 2015‑11‑20
KEZO Clinical Document Overdracht 2.16.840.1.113883.2.4.3.11.60.66.10.51 - 2015‑07‑13
KEZO Clinical Document Overdracht 2.16.840.1.113883.2.4.3.11.60.66.10.51 - 2014‑06‑27
KEZO Clinical Document Verwijzing 2.16.840.1.113883.2.4.3.11.60.66.10.50 - 2014‑06‑27
KEZO Generieke Groepering 2.16.840.1.113883.2.4.3.11.60.66.10.200 - 2014‑08‑18
KEZO Generieke Groepering 2.16.840.1.113883.2.4.3.11.60.66.10.200 - 2014‑07‑21
|
|||
|
|
|
|
|||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Datasets, codes, OID's en Regels: deze informatie wordt gebruikt voor weergave- en validatiedoeleinden.